Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Debt / NOTE 3.000%10/1
-
Market price (% of par)
-
143.0%
-
Total 13F principal
-
$180,346,000
-
Principal change
-
+$180,346,000
-
Total reported market value
-
$258,276,000
-
Number of holders
-
17
-
Value change
-
+$258,275,897
-
Number of buys
-
17
Institutional Holders of KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1 as of Q4 2019
As of 31 Dec 2019,
KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1 was held by
17 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$180,346,000
in principal (par value) of the bond.
The largest 10 bondholders included
DeepCurrents Investment Group LLC, CITADEL ADVISORS LLC, STEELHEAD PARTNERS LLC, FARALLON CAPITAL MANAGEMENT LLC, Linden Advisors LP, Davidson Kempner Capital Management LP, Allianz Asset Management GmbH, LAZARD ASSET MANAGEMENT LLC, Verition Fund Management LLC, and CNH PARTNERS LLC.
This page lists
18
institutional bondholders reporting positions
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.